Favipiravir: Promising Therapy for COVID-19

Abstract

COVID 19 is become one of the most threatened pandemics in recent time and spreading rapidly. Favipiravir, an antiviral drug, has shown promising but yet unproven effect against COVID-19 infection. Drug Controller General of India (DCGI) has recently approved Favipiravir for treating moderate to severe COVID-19 infected patients. Favipiravir, a broad-spectrum antiviral drug that interferes with the viral replication and emerging as promising therapeutic potential as indicated by initial clinical studies. In this literature review author tries to summaries an overview of Favipiravir as a promising therapy for COVID-19 disease.